Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Safe use of SSRIs in young adults: how strong is evidence for new suicide warning?

Literature DB >> 19458788

Safe use of SSRIs in young adults: how strong is evidence for new suicide warning?

Michael F Grunebaum¹, J John Mann.

Abstract

Year: 2007 PMID： 19458788 PMCID： PMC2674796

Source DB: PubMed Journal: Curr Psychiatr ISSN： 1537-8276

× No keyword cloud information.

31 in total

1. Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: a controlled forensic database study of 14,857 suicides.

Authors: G Isacsson; P Holmgren; J Ahlner
Journal: Acta Psychiatr Scand Date: 2005-04 Impact factor: 6.392

Review 2. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials.

Authors: Dean Fergusson; Steve Doucette; Kathleen Cranley Glass; Stan Shapiro; David Healy; Paul Hebert; Brian Hutton
Journal: BMJ Date: 2005-02-19

3. FDA panel seeks to balance risks in warnings for antidepressants.

Authors: Bridget M Kuehn
Journal: JAMA Date: 2007-02-14 Impact factor: 56.272

4. Association of suicide and antidepressant prescription rates in Japan, 1999-2003.

Authors: Atsuo Nakagawa; Michael F Grunebaum; Steven P Ellis; Maria A Oquendo; Haruo Kashima; Robert D Gibbons; J John Mann
Journal: J Clin Psychiatry Date: 2007-06 Impact factor: 4.384

5. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review.

Authors: David Gunnell; Julia Saperia; Deborah Ashby
Journal: BMJ Date: 2005-02-19

6. Suicide and antidepressants in south Alabama: evidence for improved treatment of depression.

Authors: C L Rich; G Isacsson
Journal: J Affect Disord Date: 1997-09 Impact factor: 4.839

7. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.

Authors: John March; Susan Silva; Stephen Petrycki; John Curry; Karen Wells; John Fairbank; Barbara Burns; Marisa Domino; Steven McNulty; Benedetto Vitiello; Joanne Severe
Journal: JAMA Date: 2004-08-18 Impact factor: 56.272

Safe use of SSRIs in young adults: how strong is evidence for new suicide warning?

1. Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: a controlled forensic database study of 14,857 suicides.

Review 2. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials.

3. FDA panel seeks to balance risks in warnings for antidepressants.

4. Association of suicide and antidepressant prescription rates in Japan, 1999-2003.

5. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review.

6. Suicide and antidepressants in south Alabama: evidence for improved treatment of depression.

7. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.

8. Antidepressants and the risk of suicidal behaviors.

9. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs.

10. Suicide attempts among patients starting depression treatment with medications or psychotherapy.

Review 1. Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders.